Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

DeepVerge Collaboration for Water & Soil Analysis

23 Aug 2021 07:00

RNS Number : 3801J
Microsaic Systems plc
23 August 2021
 

 

RNS Reach

 

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic collaborates with DeepVerge plc to launch range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil

 

Combined micro-engineering technology, software and AI create unique identification detection system for Chemicals of Emerging Concern[i] (CEC) including Forever Chemicals[ii] (PFAS)

 

Microsaic (AIM:MSYS), is pleased to announce continued progress through its collaboration with DeepVerge plc ("DeepVerge") (AIM: DVRG) to provide real-time monitoring solutions to detect and identify contaminants in water and soil.

 

Microsaic has launched a miniaturised mass spectrometer platform which provides fully integrated front-end solutions, with software upgrades using AI from DeepVerge, to achieve triple quadrupole limits of detection for real-time monitoring and identification of organic chemicals in water and soil. 'Triple quad' limits of detection mean increased sensitivity and specificity, which allows detection and quantitation at lower limits than conventional single quadrupole mass spectroscopy.

 

In collaboration with DeepVerge plc environmental division, who has implemented real-time services for the automated detection and identification of metals and pathogens[iii], Microsaic augments this offering now with automated real-time detection and expert analysis of dangerous organic chemicals in water and soil.

 

· Detection capability for a variety of contaminants and toxic bad actors adds:

o Organic chemical expertise and detection of CECs, currently unregulated and unmeasured, with the European Chemical Agency in 2020 identifying 290 chemical candidates for regulatory action by the European Commission[iv]

· New platform augments revenue channels of both companies without re-engineering business infrastructure:

o Screening - project deployment (e.g. site remediation, clean up, chronic or acute spills), mobile laboratory/van etc.

o Monitoring - site surveillance (e.g. waste water treatment plants, sites of special interest)

· Retrofit or standalone integration of high-tech hardware, software and AI adds:

o Unified data handling

o Unified/integrated sampling strategies

o Unified front-end to customers installations and collaborations

o Powerful and accurate analysis of aggregated data with AI delivering the ability to detect an array of targets in a single platform and with predictive alert capability

 

The new portable Microsaic platform, with triple quadrupole limits of detection is unique, bringing laboratory quality performance to the front-line, at a fraction the cost and up to 90% smaller than traditional triple quadrupole mass spectrometry equipment, reducing workflows and allowing real-time manual, or automated, decision making in real-time.

 

Glenn Tracey, CEO of Microsaic Systems plc, commented:

"The Microsaic team has achieved two major milestones: first, a range of miniaturised portable mass spectrometry systems with triple quadrupole limits of detection, and second, access to potential new sources of shared income from monitoring services that offer protection to society against the silent killer of chemicals of emerging concern."

 

"This combination of capabilities from Microsaic and DeepVerge provides impressive coverage between chemicals and pathogens in our waters and soil. The Microsaic Board believes that data-driven monitoring capability is of great interest to government, industrial and agricultural stakeholders which is already generating significant interest from prospective clients."

 

 

Gerard Brandon, DeepVerge plc CEO, commented:

"By combining our expertise in contaminant monitoring, we are able to offer new, innovative real-time monitoring solutions to our existing customers and open new global opportunities for fully-integrated water and soil detection of a broad range of pathogens and chemicals. This includes detecting the presence of COVID-SARS-CoV-2, providing the potential to identify virus hotspots more rapidly and cost effectively than by direct human testing."

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking) 

Turner Pope Investments (TPI) Limited(Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

About Microsaic (www.microsaic.com)

 

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications. 

 

About DeepVerge plc (www.deepverge.com)

 

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 


[i] https://www.microsaic.com/news/the_truth_about_the_silent_undetected_killers_in_our_waters/

[ii] https://www.microsaic.com/news/5-enivronmental-issues-real-time-diagnosis-can-help-solve/

[iii] Pathogens (virus, bacteria, toxins and parasites)

[iv] https://echa.europa.eu/-/nearly-300-chemicals-identified-as-candidates-for-regulatory-action

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDICBDDGBG
Date   Source Headline
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSHalf-year Report
26th Aug 20161:15 pmRNSProposed Placing of New Shares
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.